You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

CLINICAL TRIALS PROFILE FOR OLANZAPINE PAMOATE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for OLANZAPINE PAMOATE

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00320489 ↗ Olanzapine Pamoate Depot Versus Oral Olanzapine on Treatment Outcomes in Outpatients With Schizophrenia Completed Eli Lilly and Company Phase 3 2006-04-01 To compare the health outcome of patients with schizophrenia, who are at risk for relapse, when treated with a long acting injection form of olanzapine versus treatment with oral olanzapine.
NCT01389908 ↗ A Follow up Study of Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective Disorder Unknown status Shalvata Mental Health Center N/A 2011-06-01 The purpose of this study is to assess the long-term efficacy of Olanzapine Pamoate (OP) Depot in patients diagnosed with schizophrenia or schizoaffective disorder.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for OLANZAPINE PAMOATE

Condition Name

Condition Name for OLANZAPINE PAMOATE
Intervention Trials
Schizophrenia 2
Schizoaffective Disorders 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for OLANZAPINE PAMOATE
Intervention Trials
Schizophrenia 2
Psychotic Disorders 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for OLANZAPINE PAMOATE

Trials by Country

Trials by Country for OLANZAPINE PAMOATE
Location Trials
United States 7
Canada 4
Romania 1
Taiwan 1
Israel 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for OLANZAPINE PAMOATE
Location Trials
Pennsylvania 1
Ohio 1
New York 1
Illinois 1
Hawaii 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for OLANZAPINE PAMOATE

Clinical Trial Phase

Clinical Trial Phase for OLANZAPINE PAMOATE
Clinical Trial Phase Trials
Phase 3 1
N/A 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for OLANZAPINE PAMOATE
Clinical Trial Phase Trials
Completed 1
Unknown status 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for OLANZAPINE PAMOATE

Sponsor Name

Sponsor Name for OLANZAPINE PAMOATE
Sponsor Trials
Shalvata Mental Health Center 1
Eli Lilly and Company 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for OLANZAPINE PAMOATE
Sponsor Trials
Other 1
Industry 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.